132 related articles for article (PubMed ID: 3897082)
1. A controlled trial using ephedrine in the treatment of obesity.
Pasquali R; Baraldi G; Cesari MP; Melchionda N; Zamboni M; Stefanini C; Raitano A
Int J Obes; 1985; 9(2):93-8. PubMed ID: 3897082
[TBL] [Abstract][Full Text] [Related]
2. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
Astrup A; Breum L; Toubro S; Hein P; Quaade F
Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
Toubro S; Astrup AV; Breum L; Quaade F
Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S69-72. PubMed ID: 8384186
[TBL] [Abstract][Full Text] [Related]
4. Comparison of an ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind multi-centre trial in general practice.
Breum L; Pedersen JK; Ahlstrøm F; Frimodt-Møller J
Int J Obes Relat Metab Disord; 1994 Feb; 18(2):99-103. PubMed ID: 8148931
[TBL] [Abstract][Full Text] [Related]
5. Does ephedrine promote weight loss in low-energy-adapted obese women?
Pasquali R; Cesari MP; Melchionda N; Stefanini C; Raitano A; Labo G
Int J Obes; 1987; 11(2):163-8. PubMed ID: 3301709
[TBL] [Abstract][Full Text] [Related]
6. [Ephedrine in the treatment of obesity. A double-blind cross-over trial of the effect of Elsinore tablets].
Lumholtz IB; Thorsteinsson B; Wamberg T; Lehnschau A; Hansen G; Spellerberg S; Lund B
Ugeskr Laeger; 1980 Jun; 142(23):1487-90. PubMed ID: 6996251
[No Abstract] [Full Text] [Related]
7. [Effect of Elsinore tablets in the treatment of obesity. A controlled clinical trial].
Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
Ugeskr Laeger; 1980 Jun; 142(23):1496-9. PubMed ID: 6996253
[No Abstract] [Full Text] [Related]
8. Scopolamine alone or combined with ephedrine in seasickness: a double-blind, placebo-controlled study.
Laitinen LA; Tokola O; Gothoni G; Vapaatalo H
Aviat Space Environ Med; 1981 Jan; 52(1):6-10. PubMed ID: 7011299
[TBL] [Abstract][Full Text] [Related]
9. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
Toubro S; Astrup A; Breum L; Quaade F
Int J Obes Relat Metab Disord; 1993 Dec; 17 Suppl 3():S73-7; discussion S82. PubMed ID: 8124407
[TBL] [Abstract][Full Text] [Related]
10. Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.
Daly PA; Krieger DR; Dulloo AG; Young JB; Landsberg L
Int J Obes Relat Metab Disord; 1993 Feb; 17 Suppl 1():S73-8. PubMed ID: 8384187
[TBL] [Abstract][Full Text] [Related]
11. Ephedrine as an anorectic: the story of the 'Elsinore pill'.
Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
Int J Obes; 1981; 5(2):183-7. PubMed ID: 7228474
[TBL] [Abstract][Full Text] [Related]
12. [Elsinore tablets and ephedrine as slimming agents].
Jensen KB; Danø P; Draeby N; Hansen SH; Kanstrup J
Ugeskr Laeger; 1980 Jun; 142(23):1499-501. PubMed ID: 6996254
[No Abstract] [Full Text] [Related]
13. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
Molnár D; Török K; Erhardt E; Jeges S
Int J Obes Relat Metab Disord; 2000 Dec; 24(12):1573-8. PubMed ID: 11126208
[TBL] [Abstract][Full Text] [Related]
14. Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial.
Zelissen PM; Stenlof K; Lean ME; Fogteloo J; Keulen ET; Wilding J; Finer N; Rössner S; Lawrence E; Fletcher C; McCamish M;
Diabetes Obes Metab; 2005 Nov; 7(6):755-61. PubMed ID: 16219020
[TBL] [Abstract][Full Text] [Related]
15. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
Muls E; Kolanowski J; Scheen A; Van Gaal L;
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
[TBL] [Abstract][Full Text] [Related]
16. Muscle uncoupling protein 3 expression is unchanged by chronic ephedrine/caffeine treatment: results of a double blind, randomised clinical trial in morbidly obese females.
Bracale R; Petroni ML; Davinelli S; Bracale U; Scapagnini G; Carruba MO; Nisoli E
PLoS One; 2014; 9(6):e98244. PubMed ID: 24905629
[TBL] [Abstract][Full Text] [Related]
17. Responses of brown adipose tissue to diet-induced obesity, exercise, dietary restriction and ephedrine treatment.
Slocum N; Durrant JR; Bailey D; Yoon L; Jordan H; Barton J; Brown RH; Clifton L; Milliken T; Harrington W; Kimbrough C; Faber CA; Cariello N; Elangbam CS
Exp Toxicol Pathol; 2013 Jul; 65(5):549-57. PubMed ID: 22542811
[TBL] [Abstract][Full Text] [Related]
18. Objective and subjective assessment of ephedrine combinations in asthmatic outpatients.
Muittari A; Mattila MJ
Ann Clin Res; 1979 Jun; 11(3):87-9. PubMed ID: 386912
[TBL] [Abstract][Full Text] [Related]
19. [Elsinore banting tablets. A controlled clinical trial in general practice].
Roed P; Hansen PW; Bidstrup B; Kaern M; Helles A; Petersen KP
Ugeskr Laeger; 1980 Jun; 142(23):1491-5. PubMed ID: 6996252
[No Abstract] [Full Text] [Related]
20. Effects of dexfenfluramine treatment on body weight and postprandial thermogenesis in obese subjects. A double-blind placebo-controlled study.
Lafreniere F; Lambert J; Rasio E; Serri O
Int J Obes Relat Metab Disord; 1993 Jan; 17(1):25-30. PubMed ID: 8383638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
